Livforsakringsbolaget Skandia, Omsesidigt Harmony Biosciences Holdings, Inc. Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.85 Billion
- Q4 2024
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 47,700 shares of HRMY stock, worth $1.64 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
47,700
Previous 44,900
6.24%
Holding current value
$1.64 Million
Previous $1.79 Million
8.48%
% of portfolio
0.09%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$228 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$163 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$78.5 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.4 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...